Sirigen
Latest round
- Series B
Last raised
- Apr 2008
Total raised
- $1.7M
Investors
- 3
About Sirigen
Sirigen Ltd., based in Ringwood, UK, specializes in advanced diagnostic solutions. In August 2012, Sirigen was acquired by Becton, Dickinson and Company for an undisclosed sum. The company has successfully engaged in 9 deals since its inception.Sirigen specializes in advanced diagnostics and analysis through its innovative product offerings, primarily focusing on multiplexed biomarker detection technology. The core products aim to enhance efficiency and accuracy in genomic and proteomic analysis, serving platforms that cater to clinical laboratories and research institutions. The products are designed to provide insights into various health conditions, facilitating personalized medicine approaches and improving patient outcomes. This technology was notably released to the market to address the growing need for precise diagnostic tools in oncology and infectious diseases.5. The revenue generation model for Sirigen involves strategic partnerships with healthcare institutions and direct sales to clinical laboratories, which utilize the company's proprietary diagnostic technologies. Transactions typically occur through B2B agreements, with clients purchasing diagnostic kits and technology solutions tailored to their specific needs. The pricing structure is influenced by the complexity and range of services offered, with flagship products commanding premium pricing due to their advanced capabilities and proven efficacy. Revenue streams are further supported by ongoing collaborations and support services provided to clients, ensuring that they maximize the utility of Sirigen's product offerings.Following the acquisition by Becton, Dickinson and Company, Sirigen is expected to enhance its product offerings and explore new market opportunities. Expansion into new markets, particularly in Asia and North America, is anticipated to occur within the next few years as the company aims to increase its footprint in the diagnostics sector.
Who invested in Sirigen
3 investors across 2 rounds
See all investors in Sirigen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sirigen
Who invested in Sirigen?
Sirigen has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sirigen raised?
Sirigen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sirigen last raise money?
Sirigen's most recent round on record is a Series B, in Apr 2008.
What does Sirigen do?
Sirigen is a biotechnology company.
Where is Sirigen headquartered?
Sirigen is headquartered in Ringwood, UK.
Which VCs invest in companies like Sirigen?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Sirigen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sirigen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.